Skip to main content

Advertisement

SpringerLink
Log in

Anthropometric characteristics and ovarian cancer risk and survival

  • Original paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Purpose

Multiple studies have examined the role of anthropometric characteristics in ovarian cancer risk and survival; however, their results have been conflicting. We investigated the associations between weight change, height and height change and risk and outcome of ovarian cancer using data from a large population-based case–control study.

Methods

Data from 699 ovarian cancer cases and 1,802 controls who participated in the HOPE study were included. We used unconditional logistic regression adjusted for age, race, number of pregnancies, use of oral contraceptives, and family history of breast or ovarian cancer to examine the associations between self-reported height and weight and height change with ovarian cancer risk. Cox proportional hazards regression models adjusted for age and stage were used to examine the association between the exposure variables and overall and progression-free survival among ovarian cancer cases.

Results

We observed an increased risk of ovarian cancer mortality and progression for gaining more than 20 pounds between ages 18–30, HR 1.36; 95% CI 1.05–1.76, and HR 1.31; 95% CI 1.04–1.66, respectively. Losing weight and gaining it back multiple times was inversely associated with both ovarian cancer risk, OR 0.78; 95% CI 0.63–0.97 for 1–4 times and OR 0.73; 95% CI 0.54–0.99 for 5–9 times, and mortality, HR 0.63; 95% CI 0.40–0.99 for 10–14 times. Finally, being taller during adolescence and adulthood was associated with increased risk of mortality. Taller stature and weight gain over lifetime were not related to ovarian cancer risk.

Conclusions

Our results suggest that height and weight and their change over time may influence ovarian cancer risk and survival. These findings suggest that biological mechanisms underlying these associations may be hormone driven and may play an important role in relation to ovarian carcinogenesis and tumor progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. SEER (2017) Cancer Stat Facts: Ovarian Cancer

  2. Bookman MA (2012) First-line chemotherapy in epithelial ovarian cancer. Clin Obstet Gynecol 55:96–113

    Article  PubMed  Google Scholar 

  3. Bae HS, Kim HJ, Hong JH, Lee JK, Lee NW, Song JY (2014) Obesity and epithelial ovarian cancer survival: a systematic review and meta-analysis. J Ovarian Res 7:41

    Article  PubMed  PubMed Central  Google Scholar 

  4. Cancer CGoESoO (2012) Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies. PLoS Med, 9:e1001200

    Article  Google Scholar 

  5. Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH, Risch HA, Yu H, Doherty JA, Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Goodman MT, Carney ME, Matsuno RK, Lurie G, Moysich K, Kjaer SK, Jensen A, Hogdall E, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Hoyo C, Moorman P, Weber RP, Cramer DW, Vitonis AF, Bandera EV, Olson SH, Rodriguez-Rodriguez L, King M, Brinton LA, Yang H, Garcia-Closas M, Lissowska J, Anton-Culver H, Ziogas A, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Webb PM, A.C.S.O. Cancer., A.O.C.S. Group, O.C.A. Consortium (2013) Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium, Endocr Relat Cancer, 20:251–262

    Article  PubMed  Google Scholar 

  6. Nagle CM, Dixon SC, Jensen A, Kjaer SK, Modugno F, deFazio A, Fereday S, Hung J, Johnatty SE, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Van Nieuwenhuysen E, Lambrechts S, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Chang-Claude J, Goodman MT, Ness RB, Moysich K, Heitz F, du Bois A, Harter P, Schwaab I, Matsuo K, Hosono S, Goode EL, Vierkant RA, Larson MC, Fridley BL, Høgdall C, Schildkraut JM, Weber RP, Cramer DW, Terry KL, Bandera EV, Paddock L, Rodriguez-Rodriguez L, Wentzensen N, Yang HP, Brinton LA, Lissowska J, Høgdall E, Lundvall L, Whittemore A, McGuire V, Sieh W, Rothstein J, Sutphen R, Anton-Culver H, Ziogas A, Pearce CL, Wu AH, Webb PM, A.O.C.S. Group, O.C.A. Consortium (2015) Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium. Br J Cancer, 113:817–826

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kabat GC, Heo M, Kamensky V, Miller AB, Rohan TE (2013) Adult height in relation to risk of cancer in a cohort of Canadian women. Int J Cancer 132:1125–1132

    Article  CAS  PubMed  Google Scholar 

  8. Kabat GC, Anderson ML, Heo M, Hosgood HD, Kamensky V, Bea JW, Hou L, Lane DS, Wactawski-Wende J, Manson JE, Rohan TE (2013) Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 22:1353–1363

    Article  CAS  PubMed  Google Scholar 

  9. Aune D, Navarro Rosenblatt DA, Chan DS, Abar L, Vingeliene S, Vieira AR, Greenwood DC, Norat T (2015) Anthropometric factors and ovarian cancer risk: a systematic review and nonlinear dose-response meta-analysis of prospective studies. Int J Cancer 136:1888–1898

    Article  CAS  PubMed  Google Scholar 

  10. World Cancer Research Fund/American Institute for Cancer Research, Ovarian Cancer 2014 Report: Food, nutrition, physical activity, and the prevention of ovarian cancer, AICR, Washington DC, 2014

    Google Scholar 

  11. Kotsopoulos J, Moody JR, Fan I, Rosen B, Risch HA, McLaughlin JR, Sun P, Narod SA (2012) Height, weight, BMI and ovarian cancer survival. Gynecol Oncol 127:83–87

    Article  PubMed  Google Scholar 

  12. Wirén S, Häggström C, Ulmer H, Manjer J, Bjørge T, Nagel G, Johansen D, Hallmans G, Engeland A, Concin H, Jonsson H, Selmer R, Tretli S, Stocks T, Stattin P (2014) Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control 25:151–159

    Article  PubMed  Google Scholar 

  13. Song YM, Sung J (2008) Adult height and the risk of mortality in South Korean women. Am J Epidemiol 168:497–505

    Article  PubMed  Google Scholar 

  14. Rodriguez C, Calle EE, Fakhrabadi-Shokoohi D, Jacobs EJ, Thun MJ (2002) Body mass index, height, and the risk of ovarian cancer mortality in a prospective cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 11:822–828

    PubMed  Google Scholar 

  15. Bandera EV, Qin B, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Peters ES, Schwartz AG, Terry P, Schildkraut JM (2016) Obesity, weight gain, and ovarian cancer risk in African American women. Int J Cancer 139:593–600

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Ma X, Beeghly-Fadiel A, Shu XO, Li H, Yang G, Gao YT, Zheng W (2013) Anthropometric measures and epithelial ovarian cancer risk among Chinese women: results from the Shanghai Women’s Health Study. Br J Cancer 109:751–755

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Schouten LJ, Goldbohm RA, van den Brandt PA (2003) Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol 157:424–433

    Article  PubMed  Google Scholar 

  18. Fairfield KM, Willett WC, Rosner BA, Manson JE, Speizer FE, Hankinson SE (2002) Obesity, weight gain, and ovarian cancer. Obstet Gynecol 100:288–296

    PubMed  Google Scholar 

  19. Jonsson F, Wolk A, Pedersen NL, Lichtenstein P, Terry P, Ahlbom A, Feychting M (2003) Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer 106:594–599

    Article  CAS  PubMed  Google Scholar 

  20. Lubin F, Chetrit A, Freedman LS, Alfandary E, Fishler Y, Nitzan H, Zultan A, Modan B (2003) Body mass index at age 18 years and during adult life and ovarian cancer risk. Am J Epidemiol 157:113–120

    Article  CAS  PubMed  Google Scholar 

  21. Lo-Ciganic WH, Zgibor JC, Bunker CH, Moysich KB, Edwards RP, Ness RB (2012) Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer. Epidemiology 23:311–319

    Article  PubMed  PubMed Central  Google Scholar 

  22. Ness RB, Dodge RC, Edwards RP, Baker JA, Moysich KB (2011) Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer. Ann Epidemiol 21:188–196

    Article  PubMed  Google Scholar 

  23. Minlikeeva AN, Freudenheim JL, Lo-Ciganic WH, Eng KH, Friel G, Diergaarde B, Modugno F, Cannioto R, Gower E, Szender JB, Grzankowski K, Odunsi K, Ness RB, Moysich KB (2015) Use of Common Analgesics Is Not Associated with Ovarian Cancer Survival. Cancer Epidemiol Biomarkers Prev 24:1291–1294

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. McGee J, Kotsopoulos J, Lubinski J, Lynch HT, Rosen B, Tung N, Kim-Sing C, Karlan B, Foulkes WD, Ainsworth P, Ghadirian P, Senter L, Eisen A, Sun P, Narod SA, H.B.C.C.S. Group (2012) Anthropometric measures and risk of ovarian cancer among BRCA1 and BRCA2 mutation carriers. Obesity 20:1288–1292

    Article  CAS  PubMed  Google Scholar 

  25. Greer JB, Modugno F, Ness RB, Allen GO (2006) Anthropometry and the risk of epithelial ovarian cancer. Cancer 106:2247–2257

    Article  PubMed  Google Scholar 

  26. Physical status: the use and interpretation of anthropometry (1995) Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 854:1–452

    Google Scholar 

  27. Collaboration ERF (2012) Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. Int J Epidemiol 41:1419–1433

    Article  Google Scholar 

  28. Batty GD, Barzi F, Woodward M, Jamrozik K, Woo J, Kim HC, Ueshima H, Huxley RR, A.P.C.S. Collaboration (2010) Adult height and cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration. Ann Oncol 21:646–654

    Article  CAS  PubMed  Google Scholar 

  29. Rosenfeld RG (2003) Insulin-like growth factors and the basis of growth. N Engl J Med 349:2184–2186

    Article  CAS  PubMed  Google Scholar 

  30. Lukanova A, Kaaks R (2005) Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 14:98–107

    CAS  PubMed  Google Scholar 

  31. Wang HS, Chard T (1999) IGFs and IGF-binding proteins in the regulation of human ovarian and endometrial function. J Endocrinol 161:1–13

    Article  CAS  PubMed  Google Scholar 

  32. Zhang B, Shu XO, Delahanty RJ, Zeng C, Michailidou K, Bolla MK, Wang Q, Dennis J, Wen W, Long J, Li C, Dunning AM, Chang-Claude J, Shah M, Perkins BJ, Czene K, Darabi H, Eriksson M, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Lambrechts D, Neven P, Wildiers H, Floris G, Schmidt MK, Rookus MA, van den Hurk K, de Kort WL, Couch FJ, Olson JE, Hallberg E, Vachon C, Rudolph A, Seibold P, Flesch-Janys D, Peto J, Dos-Santos-Silva I, Fletcher O, Johnson N, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Li J, Humphreys K, Brand J, Guénel P, Truong T, Cordina-Duverger E, Menegaux F, Burwinkel B, Marme F, Yang R, Surowy H, Benitez J, Zamora MP, Perez JI, Cox A, Cross SS, Reed MW, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Chenevix-Trench G, Haiman CA, Henderson BE, Schumacher F, Marchand LL, Lindblom A, Margolin S, Hooning MJ, Martens JW, Tilanus-Linthorst MM, Collée JM, Hopper JL, Southey MC, Tsimiklis H, Apicella C, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Giles GG, Milne RL, McLean C, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Swerdlow AJ, Ashworth A, Orr N, Jones M, Figueroa J, Garcia-Closas M, Brinton L, Lissowska J, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Brauch H, Brüning T, Ko YD, Peterlongo P, Manoukian S, Bonanni B, Radice P, Bogdanova N, Antonenkova N, Dörk T, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Devilee P, Seynaeve C, Van Asperen CJ, Jakubowska A, Lubiński J, Jaworska-Bieniek K, Durda K, Hamann U, Torres D, Schmutzler RK, Neuhausen SL, Anton-Culver H, Kristensen VN, Grenaker Alnæs GI, Pierce BL, Kraft P, Peters U, Lindstrom S, Seminara D, Burgess S, Ahsan H, Whittemore AS, John EM, Gammon MD, Malone KE, Tessier DC, Vincent D, Bacot F, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, González-Neira A, Pita G, Alonso MR, Álvarez N, Herrero D, Pharoah PD, Simard J, Hall P, Hunter DJ, Easton DF, Zheng W, A.s.O.S.G. kConFab Investigators (2015) D. Project, Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization, J Natl Cancer Inst 107

  33. Pollak MN, Schernhammer ES, Hankinson SE (2004) Insulin-like growth factors and neoplasia. Nat Rev Cancer 4:505–518

    Article  CAS  PubMed  Google Scholar 

  34. Resnicoff M, Ambrose D, Coppola D, Rubin R (1993) Insulin-like growth factor-1 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines. Lab Investig 756–760

  35. Chakrabarty S, Kondratick L (2006) Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogen-activated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells. Cancer Biol Ther 5:189–197

    Article  CAS  PubMed  Google Scholar 

  36. Lee EJ, Mircean C, Shmulevich I, Wang H, Liu J, Niemistö A, Kavanagh JJ, Lee JH, Zhang W (2005) Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion. Mol Cancer 4:7

    Article  PubMed  PubMed Central  Google Scholar 

  37. King SM, Modi DA, Eddie SL, Burdette JE (2013) Insulin and insulin-like growth factor signaling increases proliferation and hyperplasia of the ovarian surface epithelium and decreases follicular integrity through upregulation of the PI3-kinase pathway. J Ovarian Res 6:12

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Green J, Cairns BJ, Casabonne D, Wright FL, Reeves G, Beral V, M.W.S. Collaborators (2011) Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 12:785–794

    Article  PubMed  PubMed Central  Google Scholar 

  39. Baer HJ, Hankinson SE, Tworoger SS (2008) Body size in early life and risk of epithelial ovarian cancer: results from the Nurses’ Health Studies. Br J Cancer 99:1916–1922

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Sung J, Song YM, Lawlor DA, Smith GD, Ebrahim S (2009) Height and site-specific cancer risk: a cohort study of a korean adult population. Am J Epidemiol 170:53–64

    Article  PubMed  Google Scholar 

  41. Engeland A, Tretli S, Bjørge T (2003) Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 95:1244–1248

    Article  PubMed  Google Scholar 

  42. Chionh F, Baglietto L, Krishnan K, English DR, MacInnis RJ, Gertig DM, Hopper JL, Giles GG (2010) Physical activity, body size and composition, and risk of ovarian cancer. Cancer Causes Control 21:2183–2194

    Article  PubMed  Google Scholar 

  43. Lacey JV, Leitzmann M, Brinton LA, Lubin JH, Sherman ME, Schatzkin A, Schairer C (2006) Weight, height, and body mass index and risk for ovarian cancer in a cohort study. Ann Epidemiol 16:869–876

    Article  PubMed  Google Scholar 

  44. Lahmann PH, Cust AE, Friedenreich CM, Schulz M, Lukanova A, Kaaks R, Lundin E, Tjønneland A, Halkjaer J, Severinsen MT, Overvad K, Fournier A, Chabbert-Buffet N, Clavel-Chapelon F, Dossus L, Pischon T, Boeing H, Trichopoulou A, Lagiou P, Naska A, Palli D, Grioni S, Mattiello A, Tumino R, Sacerdote C, Redondo ML, Jakszyn P, Sánchez MJ, Tormo MJ, Ardanaz E, Arriola L, Manjer J, Jirström K, Bueno-de-Mesquita HB, May AM, Peeters PH, Onland-Moret NC, Bingham S, Khaw KT, Allen NE, Spencer E, Rinaldi S, Slimani N, Chajes V, Michaud D, Norat T, Riboli E (2010) Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 126:2404–2415

    CAS  PubMed  Google Scholar 

  45. Weiderpass E, Sandin S, Inoue M, Shimazu T, Iwasaki M, Sasazuki S, Sawada N, Yamaji T, Tsugane S (2012) Risk factors for epithelial ovarian cancer in Japan - results from the Japan Public Health Center-based Prospective Study cohort. Int J Oncol 40:21–30

    PubMed  Google Scholar 

  46. Kabat GC, Kim MY, Hollenbeck AR, Rohan TE (2014) Attained height, sex, and risk of cancer at different anatomic sites in the NIH-AARP diet and health study. Cancer Causes Control 25:1697–1706

    Article  PubMed  Google Scholar 

  47. Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579–591

    Article  CAS  PubMed  Google Scholar 

  48. Renehan AG, Zwahlen M, Egger M (2015) Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer 15:484–498

    Article  CAS  PubMed  Google Scholar 

  49. Byers T, Sedjo RL (2011) Does intentional weight loss reduce cancer risk? Diabetes Obes Metab 13:1063–1072

    Article  CAS  PubMed  Google Scholar 

  50. Fagherazzi G, Vilier A, Boutron-Ruault MC, Clavel-Chapelon F, Mesrine S (2012) Height, sitting height, and leg length in relation with breast cancer risk in the E3N cohort. Cancer Epidemiol Biomarkers Prev 21:1171–1175

    Article  PubMed  Google Scholar 

  51. Praestegaard C, Jensen A, Jensen SM, Nielsen TS, Webb PM, Nagle CM, DeFazio A, Høgdall E, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, Ness RB, Edwards R, Matsuo K, Hosono S, Goode EL, Winham SJ, Fridley BL, Cramer DW, Terry KL, Schildkraut JM, Berchuck A, Bandera EV, Paddock LE, Massuger LF, Wentzensen N, Pharoah P, Song H, Whittemore A, McGuire V, Sieh W, Rothstein J, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pearce CL, Pike M, Lee AW, Sutphen R, Chang-Claude J, Risch HA, Kjaer SK, A.O.C.S. Group., O.C.A. Consortium (2017) Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies. Int J Cancer 140:2422–2435

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

A. N. Minlikeeva was supported by NIH/NCI 4R25CA113951 and NIH/NCI P50CA159981; K. B. Moysich was supported by NIH/NCI P50CA159981, NIH/NCI 5R01CA188900, and the Roswell Park Alliance; B. H. Segal, J. L. Etter were supported by NIH/NCI 5R01CA188900, NIH/NCI P50CA159981; B. Diergaarde, F. Modugno, and R. Ness were supported by NIH/NCI R01CA095023, NIH/NCI R01CA126841, and NIH/NCI P50CA159981; K. Odunsi was supported by the Roswell Park Alliance Foundation and NIH/NCI P50CA159981; F. Modugno was supported by the US Army Medical Research and Materiel Command DAMD17-02-01-0669 and NIH/NCI P50CA159981; J. B. Szender, K. Starbuck, and P. C. Mayor were supported by the NIH T32 training Grant T32CA108456.

Author information

Author notes

  1. Albina N. Minlikeeva and Kirsten B. Moysich have contributed equally to this study.

Authors and Affiliations

  1. Department of Cancer Prevention and Control, Roswell Park Cancer Institute, A-352 Carlton House, Elm and Carlton Streets, Buffalo, NY, 14263, USA

    Albina N. Minlikeeva, Kirsten B. Moysich, John L. Etter & Rikki A. Cannioto

  2. Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA

    Paul C. Mayor, Kristen Starbuck, Sashikant Lele & Kunle Odunsi

  3. The University of Texas School of Public Health, Houston, TX, USA

    Roberta B. Ness

  4. Ovarian Cancer Center of Excellence, Womens Cancer Research Program, Magee-Womens Research Institute, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA

    Robert P. Edwards & Francesmary Modugno

  5. Department of Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, NY, USA

    Brahm H. Segal

  6. Department of Human Genetics, University of Pittsburgh Graduate School of Public Health, and University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA

    Brenda Diergaarde

  7. Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    Francesmary Modugno

  8. Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA

    Francesmary Modugno

Authors
  1. Albina N. Minlikeeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kirsten B. Moysich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul C. Mayor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John L. Etter
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rikki A. Cannioto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Roberta B. Ness
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kristen Starbuck
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Robert P. Edwards
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Brahm H. Segal
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Sashikant Lele
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Kunle Odunsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Brenda Diergaarde
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Francesmary Modugno
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kirsten B. Moysich.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Minlikeeva, A.N., Moysich, K.B., Mayor, P.C. et al. Anthropometric characteristics and ovarian cancer risk and survival. Cancer Causes Control 29, 201–212 (2018). https://doi.org/10.1007/s10552-017-0997-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-017-0997-5

Keywords

Search

Navigation